SCHEMBL7979485

SCHEMBL7979485

CCCCOC(=O)Oc1ccc(OC(=O)OCCCC)nn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 3/20 0.49
TSHR P16473 5/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 4/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
MAPK1 P28482 2/20 0.45
ESR1 P03372 2/20 0.45
CYP2D6 P10635 1/20 0.45
NR1H2 P55055 1/20 0.45
RNASEL Q05823 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 3/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 1/20 0.44
PDE4D Q08499 1/20 0.44
HPGD P15428 1/20 0.43
RECQL P46063 1/20 0.43
TP53 P04637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5132689 0.82 MAPT (0.48) ELANETSHRL3MBTL1TDP1LMNA
SCHEMBL9565271 0.77 ELANE (0.42) ELANETSHRL3MBTL1TDP1LMNA
SCHEMBL3063886 0.75 ESR1 (0.62) ELANETSHRL3MBTL1TDP1LMNA
SCHEMBL730122 0.75 TSHR (0.56) ELANETSHRL3MBTL1TDP1LMNA
SCHEMBL727948 0.75 ELANE (0.52) ELANETSHRL3MBTL1TDP1LMNA
SCHEMBL17473094 0.74 TSHR (0.50) ELANETSHRL3MBTL1TDP1LMNA
SCHEMBL30004141 0.74 TSHR (0.54) ELANETSHRL3MBTL1TDP1LMNA
SCHEMBL29315128 0.74 ELANE (0.62) ELANETSHRL3MBTL1TDP1LMNA
SCHEMBL19583391 0.74 TSHR (0.54) ELANETSHRL3MBTL1TDP1LMNA
SCHEMBL27800285 0.74 TSHR (0.54) ELANETSHRL3MBTL1TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001007415-A1 METHOD OF PRODUCING PYRIDAZINE-3,6-DICARBOXYLIC ACID ESTERS LONZA AG (CH) 2001-02-01 WO disclosed